Live feed
Filing
SC 13G/A
SC 13G/A0000947871-16-001330·SUNOVION CNS DEVELOPMENT CANADA ULC
Schedule 13G ownership disclosure
Cynapsus Therapeutics Inc.
Security class unavailable · CUSIP: 23257Y859
Event date: 2016-07-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-16-001330
- Form type
- SC 13G/A
- Filer
- SUNOVION CNS DEVELOPMENT CANADA ULC
- CIK
- CIK 1532079
- Filed
- Jul 08, 2016
- Reporting period
- Jul 06, 2016
- Description
- Schedule 13G beneficial ownership